Literature DB >> 27891403

Efficacy of Transcutaneous Electrical Nerve Stimulation in the Treatment of Overactive Bladder.

Nidhi Sharma1, Kaja Rekha2, Krishnamurthy Jayashree Srinivasan3.   

Abstract

INTRODUCTION: Overactive Bladder (OAB) accounts for 40-70% cases of incontinence. The etiology is unknown though detrusor instability is found in urodynamic evaluation of almost all cases. Detrusor instability or hyperreflexia can be inhibited by direct inhibition of impulses in the pre-ganglionic afferent neuron or by inhibition of bladder pre-ganglionic neurons of the efferent limb of micturition reflex. Transcutaneous Electrical Nerve Stimulation (TENS) is based on the gate control theory of abolishing the local micturition reflex arc. AIM: To assess the effectiveness and safety of TENS in idiopathic OAB.
MATERIALS AND METHODS: It is a prospective experimental study to evaluate the effectiveness of TENS v/s placebo in reducing OAB symptoms. (n1=20, n2 =20). Ten treatment sessions (5 sessions/week) of 30 minutes, were conducted.
RESULTS: There was a significant improvement in Overactive Bladder Symptom Scores (OABSS) in TENS group and 2 patients were completely dry following TENS therapy.
CONCLUSION: In elderly women, patients with OAB where other co-medications have their own anticholinergic side effects and impairment of cognition is a concern, TENS can be a useful intervention. TENS units are safe, economical and easily commercially available.

Entities:  

Keywords:  Detrusor instability; Gateway control; Urinary incontinence

Year:  2016        PMID: 27891403      PMCID: PMC5121741          DOI: 10.7860/JCDR/2016/21683.8729

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

Review 1.  TENS: a treatment option for bladder dysfunction.

Authors:  S E Bristow; S T Hasan; D E Neal
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

2.  Anticholinergic therapy: do the patients take the pills prescribed?

Authors:  Katharina Jundt; Kathrin Schreyer; Klaus Friese; Ursula Peschers
Journal:  Arch Gynecol Obstet       Date:  2010-11-03       Impact factor: 2.344

3.  Promoted healing of leprous ulcers by transcutaneous nerve stimulation.

Authors:  B Kaada; M Emru
Journal:  Acupunct Electrother Res       Date:  1988       Impact factor: 0.143

4.  Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome?

Authors:  Marc Tellenbach; Marc Schneider; Livio Mordasini; George N Thalmann; Thomas M Kessler
Journal:  World J Urol       Date:  2012-05-24       Impact factor: 4.226

5.  Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) study.

Authors:  Karin S Coyne; Mary Kay Margolis; Zoe S Kopp; Steven A Kaplan
Journal:  Urology       Date:  2011-11-04       Impact factor: 2.649

6.  Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.

Authors:  Hsin-Tzu Liu; Heng Lin; Hann-Chorng Kuo
Journal:  Neurourol Urodyn       Date:  2011-08-08       Impact factor: 2.696

7.  Efficacy of electrical nerve stimulation for chronic musculoskeletal pain: a meta-analysis of randomized controlled trials.

Authors:  Michael Johnson; Melissa Martinson
Journal:  Pain       Date:  2007-03-23       Impact factor: 6.961

8.  Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.

Authors:  G Vijaya; R Cartwright; A Derpapas; P Gallo; R Fernando; V Khullar
Journal:  Int Urogynecol J       Date:  2013-02-02       Impact factor: 2.894

9.  Patient-reported reasons for discontinuing overactive bladder medication.

Authors:  Joshua S Benner; Michael B Nichol; Eric S Rovner; Zhanna Jumadilova; Jose Alvir; Mohamed Hussein; Kristina Fanning; Jeffrey N Trocio; Linda Brubaker
Journal:  BJU Int       Date:  2009-11-12       Impact factor: 5.588

Review 10.  Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain.

Authors:  Josimari M DeSantana; Deirdre M Walsh; Carol Vance; Barbara A Rakel; Kathleen A Sluka
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

View more
  1 in total

1.  Different electrode positioning for transcutaneous electrical nerve stimulation in the treatment of urgency in women: a study protocol for a randomized controlled clinical trial.

Authors:  Juliana Falcão Padilha; Mariana Arias Avila; Enio Júnior Seidel; Patricia Driusso
Journal:  Trials       Date:  2020-02-11       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.